Medicus Sciences Acquisition in an 8-K filing today disclosed it is negotiating a non-binding letter of intent regarding a potential merger with Anteris Technologies, a medical tech company focused on structural heart components, including heart valves.
Sio Capital Management is both the holder of a significant equity interest in the SPAC’s sponsor, Medicus Sciences Holdings, and a significant direct and indirect holder of shares in Anteris.
Medicus raised $92 million in an IPO a year ago. Read more.
This article has been updated to reflect the fact that Medicus is negotiating a LOI.
